On Thursday, Amgen (NASDAQ: AMGN) is discontinuing its experimental weight loss pill, choosing instead to focus on its injectable drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE